NCT03563248 2025-10-01Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic CancerMassachusetts General HospitalPhase 2 Active not recruiting168 enrolled
NCT02676349 2023-09-28Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)Institut de Cancérologie de LorrainePhase 2 Active not recruiting130 enrolled